BFHIV Stock Price, News & Analysis
Company Description
BFHIV (BFHIV) is a publicly traded company.
On a trailing twelve-month basis, BFHIV reported revenue of $3.8B with net income of $518.0M and diluted earnings per share of $10.89. The company operates at a net profit margin of 13.5%.
This page provides a comprehensive overview of BFHIV stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Latest News
SEC Filings
BFHIV has filed 5 recent SEC filings, including 2 Form SCHEDULE 13G/A, 1 Form DEF 14A, 1 Form 8-K, 1 Form 4/A. The most recent filing was submitted on April 9, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BFHIV SEC filings →
Financial Highlights
BFHIV generated $3.8B in revenue over the trailing twelve months, and net income was $518.0M, reflecting a 13.5% net profit margin. Diluted earnings per share stood at $10.89. The company generated $2.1B in operating cash flow.